Skyhawk Therapeutics pulls in $8 mln seed
Waltham, Massachusetts-based Skyhawk Therapeutics Inc, a developer of small molecule therapeutics that correct RNA expression, has secured $8 million in seed funding. The investors included Alexandria Venture Investments.
23 January 2018•1 min read
